AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 201 filers reported holding AMICUS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,039,169 | -19.2% | 578,879 | -16.6% | 0.05% | -20.6% |
| Q2 2023 | $8,715,120 | +23.0% | 693,879 | 0.0% | 0.06% | +28.6% |
| Q1 2023 | $7,082,809 | -16.4% | 693,879 | 0.0% | 0.05% | -14.0% |
| Q4 2022 | $8,471,866 | +21.3% | 693,879 | +3.7% | 0.06% | +16.3% |
| Q3 2022 | $6,983,000 | -22.5% | 668,879 | -20.3% | 0.05% | -33.8% |
| Q2 2022 | $9,009,000 | -34.0% | 838,879 | +36.4% | 0.07% | -35.1% |
| Q1 2021 | $13,643,000 | -3.9% | 615,124 | 0.0% | 0.11% | +1.8% |
| Q4 2020 | $14,204,000 | +30.4% | 615,124 | -20.3% | 0.11% | +9.8% |
| Q3 2020 | $10,894,000 | -2.6% | 771,588 | +4.0% | 0.10% | -13.6% |
| Q2 2020 | $11,184,000 | +26.4% | 741,588 | -20.2% | 0.12% | +20.4% |
| Q1 2020 | $8,850,000 | -2.2% | 929,500 | 0.0% | 0.10% | +1.0% |
| Q4 2019 | $9,053,000 | +15.6% | 929,500 | -4.8% | 0.10% | -6.7% |
| Q3 2019 | $7,828,000 | -28.9% | 976,000 | +10.2% | 0.10% | -24.1% |
| Q2 2019 | $11,009,000 | +10.0% | 886,000 | +20.4% | 0.14% | +7.0% |
| Q1 2019 | $10,010,000 | +75.3% | 736,000 | +23.5% | 0.13% | +45.5% |
| Q4 2018 | $5,709,000 | -11.1% | 596,000 | +12.2% | 0.09% | +3.5% |
| Q3 2018 | $6,420,000 | -10.8% | 531,000 | +15.2% | 0.08% | -25.4% |
| Q2 2018 | $7,201,000 | +3.0% | 461,000 | -0.9% | 0.11% | -4.2% |
| Q1 2018 | $6,994,000 | -10.1% | 465,000 | -14.0% | 0.12% | -11.9% |
| Q4 2017 | $7,776,000 | +6.9% | 540,400 | +12.0% | 0.14% | +6.3% |
| Q3 2017 | $7,275,000 | -9.3% | 482,400 | -39.5% | 0.13% | -15.9% |
| Q2 2017 | $8,025,000 | +54.8% | 796,900 | +9.6% | 0.15% | +51.0% |
| Q1 2017 | $5,183,000 | +21.0% | 726,900 | -15.7% | 0.10% | +2.0% |
| Q4 2016 | $4,283,000 | -41.4% | 861,900 | -12.7% | 0.10% | -44.3% |
| Q3 2016 | $7,303,000 | +88.4% | 986,900 | +39.0% | 0.18% | +74.3% |
| Q2 2016 | $3,876,000 | -25.6% | 709,900 | +14.5% | 0.10% | -22.3% |
| Q1 2016 | $5,210,000 | -29.7% | 619,900 | -18.9% | 0.13% | -34.3% |
| Q4 2015 | $7,411,000 | -43.9% | 764,000 | -19.1% | 0.20% | -38.9% |
| Q3 2015 | $13,207,000 | -20.2% | 944,000 | -19.3% | 0.32% | -6.1% |
| Q2 2015 | $16,555,000 | +12.7% | 1,170,000 | -13.3% | 0.34% | +16.6% |
| Q1 2015 | $14,691,000 | +154.1% | 1,350,000 | +94.2% | 0.30% | +144.6% |
| Q4 2014 | $5,782,000 | – | 695,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Diversified Trust Co | 62,695 | $889,642 | 0.03% |
| FULTON BANK, N.A. | 11,429 | $162,177 | 0.01% |
| DnB Asset Management AS | 24,836 | $352,423 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 78 | $1,107 | 0.00% |
| Versant Capital Management, Inc | 28 | $397 | 0.00% |